期刊文献+

肺表面活性蛋白A和社区获得性肺炎预后的相关性研究 被引量:7

A Correlation Study of the Prognosis of Community Acquired Pneumonia and Pulmonary Surfactant Protein A
下载PDF
导出
摘要 目的探讨肺表面活性蛋白A(SP-A)和社区获得性肺炎(CAP)预后的相关性。方法随机选取南方医科大学珠江医院2011年9月—2013年10月100例CAP患者,按病情CURB-65评估标准将患者分为轻度组、中度组和重度组;依照CAP危重评级的标准[7],将患者分为低危组、中危组、高危组、极高危组,组间比较临床预后指标(住院时间、机械通气和氧合指数)的差异。结果中度组与重度组患者的SP-A含量、氧合指数均显著低于轻度组(P<0.05),住院时间、机械通气时间均显著高于轻度组(P<0.05);中危组、高危组、极高危组患者的SP-A含量、氧合指数均显著低于低危组(P<0.05),住院时间、机械通气时间均显著高于低危组(P<0.05)。结论 SP-A是一种敏感、准确的生物特异性指标,在CAP病情程度和预后中具有重要的评估价值。 Objective To study the correlation between prognosis of community acquired pneumonia ( CAP) and pulmonary surfactant protein A (SP-A) . Methods A total of 100 CAP patients were randomly selected from Zhujiang Hospital of Southern Medical University during September 2011 and October 2013. The patients were divided into mild group, moderate group and severe group according to the CURB-65 evaluation criteria, and were divided into mild risk group, moderate risk group, high risk group and very high risk group according to critical rating standard. The differences of clinical prognostic indexes ( hospitalization time, mechanical ventilation and oxygenation index) were compared among the groups according to the same standard. Results The levels of SP-A content and oxygenation index in moderate and severe groups were significantly lower than that in mild group (P〈0. 05), and hospitalization and mechanical ventilation times were significantly longer than that in mild group (P〈0. 05);the levels of SP-A content and oxygenation index in medium risk, high risk and very high risk groups were significantly lower than that in low risk group (P〈0. 05), while the hospitalization and mechanical ventilation times were significantly longer than that in low risk group ( P 〈0. 05 ) . Conclusion SP-A is a sensitive and accurate biological specificity index, and it has important assessment value in dis-ease severity degree and prognosis of community acquired pneumonia.
出处 《解放军医药杂志》 CAS 2014年第10期74-77,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 惠州市科学技术项目(0034293150309031)
关键词 肺表面活性蛋白A 社区获得性肺炎 预后 Pulmonary surfactant protein A Community acquired pneumonia Prognosis
  • 相关文献

参考文献20

  • 1Chalmers J D, Rutherford J. Can we use severity assess- ment tools to increase outpatient management of communi- ty-acquired pneumonia? [ J]. Eur J Intern Med, 2012,23 (5) :398-406.
  • 2Polverino E, Torres Marti A. Community-acquired pneu- monia[ J ]. Minerva Anestesiol, 2011,77 ( 2 ) : 196-211.
  • 3Atochina E N, Beck J M, Scanlon S T, et al. Pneumo- cystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D [ J]. J Lab Clin Med, 2001 , 137 (6) :429-439.
  • 4Fernandez-Real J M, Chico B, Shiratori M, et al. Circu- lating surfactant protein A (SP-A) , a marker of lung in- jury, is associated with insulin resistance [ J ]. Diabetes Care, 2008,31 ( 5 ) :958-963.
  • 5Mandell L A, Wunderink R G, Anzurto A, et al. Infec- tious Diseases Society of America/American Thoracic So- ciety consensus guidelines on the management of commu- nity acquired pneumonia in adults [ J]. Clin Infect Dis, 2007,44 ( $2 ) : 27-72.
  • 6Haque R, Umstead T M, Ponnuru P, et al. Role of sur- factant protein-A (SP-A) in lung injury in response to a- cute ozone exposure of SP-A deficient mice [ ]. Toxicol Appl Pharmacol, 2007,220( 1 ) :72-82.
  • 7井军虎,李立宇.社区获得性肺炎患者血清和肽素水平变化及其与降钙素原和C反应蛋白的相关性研究[J].实用医学杂志,2014,30(12):2010-2011. 被引量:9
  • 8GuoQ, LiH Y, ZhouYP, etal. Weight of the CURB- 65 Criteria for Community-Acquired Pneumonia in a Very Low-Mortality-Rate Setting [ J ]. Intern Med, 2012, 51 (18) :2521-2527.
  • 9Richards G, Levy H, Laterre P F, et al. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS[J]. J Intensive Care Med, 2011,26(1) :34- 40.
  • 10Ronan D, Nathwani D, Davey P, et al. Predicting mor- tality in patients with community-acquired pneumonia and low CURB-65 scores [ J ]. Eur J Clin Microbiol Infect Dis, 2010,29(9) :1117-1124.

二级参考文献33

  • 1[1]Assicot M, Gendrel D, Carsin H et al. High serum procalci tonin concertrations in patiens with sepsis and infection. Lancet,1993, 341 (88 44):515~18
  • 2[3]F Moulin, J Raymond, M Lorro et al. procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child, 2001, 84(6) 332~6
  • 3[4]Toikka P,Virkkl Rs Mertsoia J et al. Bacteremic pneumococcal pneumonia in children. Clin Infect Dis, 1999,29(3):568~72
  • 4[5]Jaye DL,Wakes KB.Clinical applications of C reactive protein in pediatrics. Pediatr Infect Dis J,1997, 16(8): 735~47
  • 5[6]Hedlund J, Hansson LO. Procalcitonin and C rcactive protein in community acq u ired pneumonia:correlation with etiology and prognosis,Infection,2000,28(2):68 ~73
  • 6[7]Toiia P,Irjala K,Juven T et al. Serum procalcitonin C reactive protein a nd int erleukin 6 for distinguishing bacterial and viral pneumonia in childern,Pediatr Infect Dis J, 2000,19(7): 598~602
  • 7[8]Hatherill M,Tibby SM,Turner C et al. Procalcitonin and cytokine levels: relati onship to organ failuie and mortality in pediatric septic shock,Crit Care Med,20 00,28(7): 2591~2594
  • 8BeekerK L, Snider R, Nylen et al. Procalcitonin assay in system- icinflammation,infection and sepsis: clinical utility and limitations [ J]. Crit Care Med ,2008,36(3 ) :941-952.
  • 9Brodsk~t H, Malf ~ kov6 K, Ad6mkov(t V, et al. Significantly higher procalcitonin levels could differentiate gramnegative sepsis from gram-positive and fungal sepsis [ J ]. Clin Exp Med, 2013,13 ( 3 ) : 165-170.
  • 10Levym M, Finkm P, Marshall JC, et al. 2001 SCCM/ESICM/AC- CP/ATS/SIS. International Sepsis Definitions Conference [J].Crit Care Med,2003,31 (4) :1250-1256.

共引文献19

同被引文献93

引证文献7

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部